velaglucerase alfa

Italy

Drugs containing this active substance

  • VPRIV

    VPRIV is an enzyme replacement therapy used for the long-term treatment of patients with type 1 Gaucher disease, a genetic condition caused by a deficiency or malfunction of the glucocerebrosidase enzyme.

    Form: solution for infusion, powder for preparation

    Active substance Dosage
    velaglucerase alfa -

    ATC: A16AB10

    Manufacturer: TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH